Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMC 1553848)

Published in Clin Exp Immunol on May 01, 1973

Authors

M M Esiri, I C MacLennan, B L Hazleman

Articles citing this

Lymphocyte proliferation to artery antigen as a positive diagnostic test in polymyalgia rheumatica. Ann Rheum Dis (1975) 1.94

Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia. Clin Exp Immunol (1975) 1.38

Echovirus encephalitis and myositis in primary immunoglobulin deficiency. Arch Dis Child (1978) 1.18

Coxsackievirus B 1-induced polymyositis. Lack of disease expression in nu/nu mice. J Clin Invest (1987) 0.97

Experimental autoimmune myositis in SJL/J mice. Clin Exp Immunol (1987) 0.96

Antibodies to nuclear antigens in polymyositis: relationship to autoimmune 'overlap syndromes' and carcinoma. Ann Rheum Dis (1981) 0.89

The inflammatory myopathies. J R Soc Med (1983) 0.89

Mitogen and muscle extract induced in vitro proliferative responses in myasthenia gravis, dermatomyositis, and polymyositis. J Neurol Neurosurg Psychiatry (1975) 0.86

Impaired autologous mixed lymphocyte reaction with normal concanavalin A-induced suppression in adult polymyositis/dermatomyositis. Clin Exp Immunol (1983) 0.83

Degeneration of muscle in association with carcinoma of the bronchus. J Neurol Neurosurg Psychiatry (1975) 0.83

Experimental myositis in rats. II. The sensitivity of spleen cells to syngeneic muscle antigen. Clin Exp Immunol (1975) 0.81

Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis. J Neurol Neurosurg Psychiatry (1975) 0.80

Cellular autoimmunity to muscle: a review. Proc R Soc Med (1977) 0.75

Dermatomyositis: observations on the use of immunosuppressive therapy and review of literature. Cairo--Glasgow study group. Postgrad Med J (1978) 0.75

Cell-mediated immunity to myoglobin in polymyositis. Ann Rheum Dis (1983) 0.75

Articles cited by this

Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica. Medicine (Baltimore) (1971) 3.36

Giant-cell arteritis. A biopsy study of polymyalgia rheumatica, including one case of Takayasu's disease. Lancet (1963) 2.56

"Polymyalgia arteritica". Further clinical and histopathological studies with a report of six autopsy cases. Ann Rheum Dis (1968) 1.63

Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol (1965) 1.59

Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders. J Neurol Neurosurg Psychiatry (1969) 1.49

Experimental myositis: the in-vivo and in-vitro activity of lymph-node cells. J Pathol (1971) 1.47

Experimental allergic myositis in rats. Arthritis Rheum (1971) 1.38

Immunological aspects of polymyositis. The in vitro activity of lymphocytes on incubation with muscle antigen and with muscle cultures. Q J Med (1971) 1.35

CIRCULATING ANTIBODIES IN POLYMYOSITIS AND OTHER MUSCLE-WASTING DISORDERS. Lancet (1964) 1.26

Destruction of differentiated muscle cultures by sensitised lymphoid cells. J Pathol Bacteriol (1966) 1.24

Destruction of muscle cultures by lymphocytes from cases of polymyositis. Acta Neuropathol (1970) 1.14

Sensitized lymphocytes in muscular dystrophy: evidence for a neural factor in pathogenesis. J Neurol Neurosurg Psychiatry (1971) 1.05

Experimental immune myositis in guinea pigs. J Reticuloendothel Soc (1970) 0.94

Polymyalgia rheumatica. J Bone Joint Surg Br (1971) 0.83

Articles by these authors

Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol (1991) 5.38

Mechanism of antigen-driven selection in germinal centres. Nature (1990) 5.26

Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci U S A (1985) 4.97

Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev (1972) 4.79

Plaques, tangles and dementia. A quantitative study. J Neurol Sci (1982) 4.52

Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol (1973) 4.32

Axonal damage in acute multiple sclerosis lesions. Brain (1997) 3.88

The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes. Immunology (1970) 3.70

Shoulder disorders in the elderly: a community survey. Arthritis Rheum (1991) 3.21

Azathioprine in rheumatoid arthritis. Br Med J (1969) 3.14

A human serum immunoglobulin with specificity for certain homologous target cells, which induces target cell damage by normal human lymphocytes. Immunology (1969) 3.12

Antigen-driven selection of virgin and memory B cells. Immunol Rev (1986) 3.10

Supervision of epileptic patients taking phenytoin. Br Med J (1970) 3.09

Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis (1981) 3.08

Effect of specific antibody to target cells on their specific and non-specific interactions with lymphocytes. Nature (1968) 2.96

Thermographic changes in keyboard operators with chronic forearm pain. BMJ (1997) 2.90

Competition for receptors for immunoglobulin on cytotoxic lymphocytes. Clin Exp Immunol (1972) 2.77

Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol (1991) 2.71

Frozen shoulder: a long-term prospective study. Ann Rheum Dis (1984) 2.67

Polymyalgia rheumatica -- a clinical study with particular reference to arterial disease. J Rheumatol (1974) 2.66

Frozen shoulder: prospective clinical study with an evaluation of three treatment regimens. Ann Rheum Dis (1984) 2.60

Germinal centres in T-cell-dependent antibody responses. Immunol Today (1992) 2.47

Shoulder disorders in the elderly (a hospital study). Ann Rheum Dis (1987) 2.45

Extracorporeal shock wave therapy for lateral epicondylitis--a double blind randomised controlled trial. J Orthop Res (2002) 2.40

Extracorporeal shock wave therapy for plantar fasciitis. A double blind randomised controlled trial. J Orthop Res (2003) 2.38

Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol (2000) 2.37

The painful stiff shoulder. Rheumatol Phys Med (1972) 2.37

Axonal damage: a key predictor of outcome in human CNS diseases. Brain (2003) 2.27

Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur J Immunol (1988) 2.26

Germinal centers without T cells. J Exp Med (2000) 2.25

Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med (1996) 2.18

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci (1982) 2.17

Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology (2011) 2.15

Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet (1999) 2.11

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology (2006) 2.10

Marginal zones: the major B cell compartment of rat spleens. Eur J Immunol (1981) 2.08

Herpes simplex encephalitis. An immunohistological study of the distribution of viral antigen within the brain. J Neurol Sci (1982) 2.02

Cytotoxic lymphocytes from rats depleted of thymus processed cells. Nat New Biol (1971) 2.02

The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. II. The mechanism of target cell damage by lymphoid cells from immunized rats. Immunology (1970) 1.96

The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci (1989) 1.95

Lymphocyte proliferation to artery antigen as a positive diagnostic test in polymyalgia rheumatica. Ann Rheum Dis (1975) 1.94

T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med (1998) 1.91

Distinct short-lived and long-lived antibody-producing cell populations. Eur J Immunol (1986) 1.89

A prospective double blind dummy placebo controlled study comparing triamcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis. J Rheumatol (1990) 1.87

Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med (2000) 1.87

Wound healing after operations of patients with rheumatoid arthritis. J Bone Joint Surg Br (1973) 1.86

Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (1997) 1.84

Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol (1991) 1.82

Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis (1989) 1.81

Alpha-1-microglobulin: an indicator protein for renal tubular function. J Clin Pathol (1983) 1.80

Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J Biol Chem (1990) 1.77

Tennis elbow--a reappraisal. Br J Rheumatol (1989) 1.76

Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol (1997) 1.76

Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia (1995) 1.76

CD23: a multi-functional receptor/lymphokine? Immunol Today (1989) 1.76

Herpes Zoster. Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J Neurol Sci (1972) 1.76

Light chain isotype-associated suppression of normal plasma cell numbers in patients with multiple myeloma: Medical Research Council's Working Party for Leukaemia in Adults and the Oxford Lymphoma Group. Int J Cancer (1979) 1.75

Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis (1989) 1.74

Rotator cuff degeneration and lateral epicondylitis: a comparative histological study. Ann Rheum Dis (1994) 1.73

Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet (1992) 1.72

The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J (1983) 1.72

Extracorporeal shock-wave therapy for tendonitis of the rotator cuff. A double-blind, randomised, controlled trial. J Bone Joint Surg Br (2002) 1.71

Migrant mu+ delta+ and static mu+ delta- B lymphocyte subsets. Eur J Immunol (1982) 1.71

The cortex of the primary auditory area in Alzheimer's disease. Brain Res (1986) 1.71

The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1984) 1.71

Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry (2001) 1.70

The long-term outcome of rotator cuff tendinitis--a review study. Br J Rheumatol (1988) 1.69

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia. Arthritis Rheum (2001) 1.67

Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis (1989) 1.66

Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain (2004) 1.63

Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Neuropathol Appl Neurobiol (2000) 1.63

Failure of certain cytotoxic lymphocytes to respond mitotically to phytohaemagglutinin. Nature (1970) 1.62

The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum (1993) 1.62

Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain (2000) 1.62

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain (1997) 1.61

Diagnosis and relation to general health of shoulder disorders presenting to primary care. Rheumatology (Oxford) (2005) 1.61

A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med (1995) 1.60

Monoclonal antibody to macrophages (EMB/11) labels macrophages and microglial cells in human brain. J Clin Pathol (1986) 1.60

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol (2000) 1.60

Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain (2001) 1.60

White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke (2001) 1.59

Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (1997) 1.58

Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis (1994) 1.58

Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis (1980) 1.57

Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production. J Exp Med (1997) 1.57

Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.56

Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. Ann Rheum Dis (1987) 1.54

Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci (1983) 1.53

The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol (1997) 1.52

Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia. Br Med J (1973) 1.50

Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience (1995) 1.48

Anomalous asymmetry of fusiform and parahippocampal gyrus gray matter in schizophrenia: A postmortem study. Am J Psychiatry (2000) 1.48

The size and fibre composition of the corpus callosum with respect to gender and schizophrenia: a post-mortem study. Brain (1999) 1.47

Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool. J Exp Med (1997) 1.46

The effect of peripheral lymphocytes from patients with inflammatory joint disease on human target cells in vitro. Clin Exp Immunol (1968) 1.46

Lateral humeral epicondylitis--a study of natural history and the effect of conservative therapy. Br J Rheumatol (1983) 1.46

Is therapeutic ultrasound effective in treating soft tissue lesions? Br Med J (Clin Res Ed) (1985) 1.46

The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol (2004) 1.46

The contribution of demyelination to axonal loss in multiple sclerosis. Brain (2006) 1.46